CN109700932A - A kind of Chinese medicine composition for treating tetraparesis inability - Google Patents

A kind of Chinese medicine composition for treating tetraparesis inability Download PDF

Info

Publication number
CN109700932A
CN109700932A CN201711006106.2A CN201711006106A CN109700932A CN 109700932 A CN109700932 A CN 109700932A CN 201711006106 A CN201711006106 A CN 201711006106A CN 109700932 A CN109700932 A CN 109700932A
Authority
CN
China
Prior art keywords
parts
radix
tetraparesis
inability
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711006106.2A
Other languages
Chinese (zh)
Inventor
林序彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201711006106.2A priority Critical patent/CN109700932A/en
Publication of CN109700932A publication Critical patent/CN109700932A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The embodiment of the invention discloses a kind of Chinese medicine compositions for treating tetraparesis inability, belong to the field of Chinese medicines, be made of following raw medicines: Radix Angelicae Sinensis, Rhizoma Chuanxiong, red medicine, radix rehmanniae preparata, rhizoma atractylodis, Radix Ophiopogonis, ginseng, radix achyranthis bidentatae, the coptis, Cortex Phellodendri, Schisandra chinensis, rhizoma anemarrhenae, Cortex Eucommiae.Paste nourishing agent, tablet, capsule, syrup, granule, pill, oral solution or injection etc. can be respectively prepared in the Chinese medicine composition.The present invention is according to theory of traditional Chinese medical science, for the pathogenesis of tetraparesis inability, with " promoting menstruation relax network, replenishing and activating blood " for principle, dialectical formula is carried out to treat, to achieve the purpose that treating both manifestation and root cause of disease, have many advantages, such as good effect, have no toxic side effect, raw material is easy to get, cheap, preparation is simple, production cost is low, drug usage facilitates multiplicity.

Description

A kind of Chinese medicine composition for treating tetraparesis inability
Technical field
The present invention relates to the field of Chinese medicines more particularly to a kind of Chinese medicine compositions for treating tetraparesis inability.
Background technique
The cause of disease of tetraparesis inability is more and complicated, and the common cause of disease has myelitis, cerebral hemorrhage etc., and doctor trained in Western medicine is to spinal cord at present Tetraparesis caused by inflammation is equal is powerless without specific treatment method, and the symptom of tetraparesis inability on the life of patient influence compared with Greatly, a kind of drug that can improve this symptom is needed.
Summary of the invention
In order to compensate for the shortcomings of the prior art, the present invention provides a kind of Chinese medicine composition for treating tetraparesis inability, The present invention with " promoting menstruation relax network, replenishing and activating blood " for principle, carries out dialectical formula and treats according to theory of traditional Chinese medical science, simultaneous to reach sample The purpose controlled, has that curative effect is high, have no toxic side effect, raw material is easy to get, cheap, preparation is simple, production cost is low, drug usage The advantages that facilitating multiplicity.
In order to achieve the above object, by largely groping to summarize, the invention adopts the following technical scheme:
A kind of Chinese medicine composition for treating tetraparesis inability, it is characterised in that be made of the raw medicine of following weight ratio: Radix Angelicae Sinensis 15- 25 parts, 15-25 parts of Rhizoma Chuanxiong, medicine 15-25 parts red, 15-25 parts of radix rehmanniae preparata, 15-25 parts of rhizoma atractylodis, Radix Ophiopogonis 20-30 part, 5-15 parts of ginseng, 5-15 parts of radix achyranthis bidentatae, 5-15 parts of the coptis, 5-15 parts of Cortex Phellodendri, 5-15 parts of Schisandra chinensis, 5-15 parts of rhizoma anemarrhenae, 5-15 parts of Cortex Eucommiae.
Preferably, the Chinese medicine composition of the treatment tetraparesis inability, it is characterised in that by the raw medicine of following weight ratio Be made: 18-22 parts of Radix Angelicae Sinensis, 18-22 parts of Rhizoma Chuanxiong, medicine 18-22 parts red, 18-22 parts of radix rehmanniae preparata, 18-22 parts of rhizoma atractylodis, Radix Ophiopogonis 22-28 part, 8-12 parts of ginseng, 8-12 parts of radix achyranthis bidentatae, 8-12 parts of the coptis, 8-12 parts of Cortex Phellodendri, 8-12 parts of Schisandra chinensis, 8-12 parts of rhizoma anemarrhenae, Cortex Eucommiae 8-12 Part.
Preferably, the Chinese medicine composition of the treatment tetraparesis inability, it is characterised in that by the raw medicine of following weight ratio Be made: 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Chuanxiong, 20 parts of red medicine, 20 parts of radix rehmanniae preparata, 20 parts of rhizoma atractylodis, 25 parts of Radix Ophiopogonis, 10 parts of ginseng, 10 parts of radix achyranthis bidentatae, 10 parts of the coptis, 10 parts of Cortex Phellodendri, 10 parts of Schisandra chinensis, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Eucommiae.
Further, weigh according to quantity the above raw material, by sterile drying, be ground up, sieved powder be made.
Further, the above raw material plus 150-250 parts of water are weighed according to quantity, are boiled by fire, are boiled with soft fire 30 minutes, filter residue Obtain medical fluid.
Further, powder and/or medical fluid made of, can be by industrial production process such as concentration, mixing, compactings into one Paste nourishing agent, tablet, capsule, syrup, granule, pill, oral solution or injection etc. is made in step.
In raw materials of traditional Chinese medicinal materials compatibility selected by the present invention, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Chinese herbaceous peony, radix achyranthis bidentatae, radix rehmanniae preparata, have enrich blood, moisturize, Dissipate endogenous cold, promoting blood circulation, the effect of dissolving stasis;Rhizoma anemarrhenae, Radix Ophiopogonis, Schisandra chinensis have the function of nourshing kidney, promote the production of body fluid;The coptis, Cortex Phellodendri heat-clearing solution Poison;Ginseng, Cortex Eucommiae have the function of that promoting menstruation is relaxed network and strong;Rhizoma atractylodis clearing damp stomach function regulating, passes through the co-action for treating of the above drug Tetraparesis is powerless.
Specific embodiment
Embodiment 1
Chinese medicine composition compatibility of the invention: 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Chuanxiong, 20 parts of red medicine, 20 parts of radix rehmanniae preparata, rhizoma atractylodis 20 is weighed according to quantity Part, 25 parts of Radix Ophiopogonis, 10 parts of ginseng, 10 parts of radix achyranthis bidentatae, 10 parts of the coptis, 10 parts of Cortex Phellodendri, 10 parts of Schisandra chinensis, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Eucommiae. 150 parts of water are added, are boiled by fire, are boiled with soft fire 30 minutes, filter residue obtains medical fluid.It takes in the morning and evening.
Embodiment 2
Chinese medicine composition compatibility of the invention: 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Chuanxiong, 20 parts of red medicine, 20 parts of radix rehmanniae preparata, rhizoma atractylodis 20 is weighed according to quantity Part, 25 parts of Radix Ophiopogonis, 10 parts of ginseng, 10 parts of radix achyranthis bidentatae, 10 parts of the coptis, 10 parts of Cortex Phellodendri, 10 parts of Schisandra chinensis, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Eucommiae. Sufficiently agitation grinding is taken after mixing it with water sooner or later at powder after drying.
Embodiment 3
Chinese medicine composition compatibility of the invention: 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Chuanxiong, 20 parts of red medicine, 20 parts of radix rehmanniae preparata, rhizoma atractylodis 20 is weighed according to quantity Part, 25 parts of Radix Ophiopogonis, 10 parts of ginseng, 10 parts of radix achyranthis bidentatae, 10 parts of the coptis, 10 parts of Cortex Phellodendri, 10 parts of Schisandra chinensis, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Eucommiae. 250 parts of water are added, are boiled by fire, are boiled with soft fire 30 minutes, filter residue obtains medical fluid, is concentrated into paste.Sooner or later it takes after mixing it with water.
Embodiment 4
Chinese medicine composition compatibility of the invention: 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Chuanxiong, 20 parts of red medicine, 20 parts of radix rehmanniae preparata, rhizoma atractylodis 20 is weighed according to quantity Part, 25 parts of Radix Ophiopogonis, 10 parts of ginseng, 10 parts of radix achyranthis bidentatae, 10 parts of the coptis, 10 parts of Cortex Phellodendri, 10 parts of Schisandra chinensis, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Eucommiae. Sufficiently agitation grinding is packed into capsule, takes in the morning and evening at powder after drying.
Above disclosed is only presently preferred embodiments of the present invention, cannot limit the right of the present invention with this certainly Range, therefore equivalent changes made in accordance with the claims of the present invention, are still within the scope of the present invention.

Claims (4)

1. a kind of Chinese medicine composition for treating tetraparesis inability, it is characterised in that be made of the raw medicine of following weight proportion: when Return 15-25 parts, 15-25 parts of Rhizoma Chuanxiong, medicine 15-25 parts red, 15-25 parts of radix rehmanniae preparata, 15-25 parts of rhizoma atractylodis, Radix Ophiopogonis 20-30 part, ginseng 5- 15 parts, 5-15 parts of radix achyranthis bidentatae, 5-15 parts of the coptis, 5-15 parts of Cortex Phellodendri, 5-15 parts of Schisandra chinensis, 5-15 parts of rhizoma anemarrhenae, 5-15 parts of Cortex Eucommiae.
2. treating the Chinese medicine composition of tetraparesis inability according to claim 1, it is characterised in that by following weight proportion Raw medicine be made: 18-22 parts of Radix Angelicae Sinensis, 18-22 parts of Rhizoma Chuanxiong, medicine 18-22 parts red, 18-22 parts of radix rehmanniae preparata, 18-22 parts of rhizoma atractylodis, Radix Ophiopogonis 22-28 parts, 8-12 parts of ginseng, 8-12 parts of radix achyranthis bidentatae, 8-12 parts of the coptis, 8-12 parts of Cortex Phellodendri, 8-12 parts of Schisandra chinensis, 8-12 parts of rhizoma anemarrhenae, 8-12 parts of Cortex Eucommiae.
3. treating the Chinese medicine composition of tetraparesis inability according to claim 2, it is characterised in that by following weight proportion Raw medicine be made: 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Chuanxiong, 20 parts of red medicine, 20 parts of radix rehmanniae preparata, 20 parts of rhizoma atractylodis, 25 parts of Radix Ophiopogonis, 10 parts of ginseng, ox 10 parts of knee, 10 parts of the coptis, 10 parts of Cortex Phellodendri, 10 parts of Schisandra chinensis, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Eucommiae.
4. the Chinese medicine composition of any one of -3 treatment tetraparesis inability according to claim 1, it is characterised in that Ke Yifen Paste nourishing agent, tablet, capsule, syrup, granule, pill, oral solution or injection are not made.
CN201711006106.2A 2017-10-25 2017-10-25 A kind of Chinese medicine composition for treating tetraparesis inability Pending CN109700932A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711006106.2A CN109700932A (en) 2017-10-25 2017-10-25 A kind of Chinese medicine composition for treating tetraparesis inability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711006106.2A CN109700932A (en) 2017-10-25 2017-10-25 A kind of Chinese medicine composition for treating tetraparesis inability

Publications (1)

Publication Number Publication Date
CN109700932A true CN109700932A (en) 2019-05-03

Family

ID=66252433

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711006106.2A Pending CN109700932A (en) 2017-10-25 2017-10-25 A kind of Chinese medicine composition for treating tetraparesis inability

Country Status (1)

Country Link
CN (1) CN109700932A (en)

Similar Documents

Publication Publication Date Title
CN101297889B (en) Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof
CN102091311B (en) Traditional Chinese medicinal composition for treating rheumatoid arthritis and preparation method thereof
CN102973840B (en) Chinese traditional medicine composite for curing acne
CN104225507A (en) Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage
CN102552519A (en) Chinese medicine composition for activating blood and stopping pain, preparation process and application
CN102370767A (en) Traditional Chinese medicine formula used for treating intestinal obstruction
CN109700932A (en) A kind of Chinese medicine composition for treating tetraparesis inability
CN105327262A (en) Traditional Chinese medicine formula for treating constipation of children and preparing method of traditional Chinese medicine
CN102872287A (en) Traditional Chinese medicine composition for treating femoral head necrosis and preparation method thereof
CN109718352A (en) A kind of Chinese medicine composition for treating indigestion and water sample rushes down
CN109771621A (en) It is a kind of to treat the full Chinese medicine composition of cold limbs abdomen
CN102499979B (en) Compound propolis composition for treating dog and cat diarrhea and preparation method thereof
CN109718355A (en) A kind of Chinese medicine composition for treating limb adynamia and pain
CN109745394A (en) A kind of Chinese medicine composition for treating the dry wind-heat of blood and pruitus
CN109745440A (en) A kind of Chinese medicine composition for treating heatstroke
CN106853193A (en) It is a kind of to treat Chinese medicine of rheumatoid arthritis and preparation method thereof
CN109925405A (en) A kind of Chinese medicine composition for treating abdominal distension gas
CN109700905A (en) A kind of Chinese medicine composition for treating abdominal distension edema
CN104274774A (en) Traditional Chinese medicine composition for treating qi-stagnation blood-stasis type endometriosis
CN103550453B (en) Promote Chinese medicine composition of poultry growing and fattening and preparation method thereof
CN105395810A (en) Traditional Chinese medicine composition for treating marek's disease
CN109745432A (en) A kind of Chinese medicine composition for treating lumbago due to the kidney deficiency
CN109692320A (en) A kind of Chinese medicine composition for treating epigastric fullness and rigidity
CN109700981A (en) A kind of Chinese medicine composition for treating the cold anaemia of body
CN109771554A (en) A kind of Chinese medicine composition for treating consumptive disease

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190503